A sustained and pancellular reversal of gamma-globin gene silencing in adult human erythroid precursor cells

Natarajan V. Bhanu, Tiffany A. Trice, Y. Terry Lee, Nicole M. Gantt, Patricia Oneal, Joseph D. Schwartz, Pierre Noel, Jeffery L. Miller

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

We systematically compared cytokine-mediated increases or decreases in proliferation with globin gene and protein expression in adult human erythroblasts. Despite their opposite effects on growth, stem cell factor (SCF) and transforming growth factor-beta (TGF-B) had synergistic effects with respect to fetal hemoglobin (HbF): average HbF/HbF + adult hemoglobin (HbA) ratio in erythropoietin (EPO) = 1.4 ± 1.0%; EPO + TGF-B = 10.8 ± 1.9%; EPO + SCF = 19.1 ± 6.2%; and EPO + SCF + TGF-B (EST) = 39.3 ± 6.3%. Polymerase chain reaction (PCR) revealed significant increases in gamma-globin transcripts that were balanced by reduced beta-globin transcripts. Single-cell quantitative PCR demonstrated a complete reversal of gamma-globin gene silencing with detectable gamma-globin mRNA in more than 95% of the cells. Immunostaining with HbF antibodies also showed a pancellular distribution in EST (96.2 ± 0.01% HbF positive) compared with a heterocellular distribution in EPO (42.9 ± 0.01% HbF positive). As shown here for the first time, a robust and pancellular reversal of gamma-globin gene silencing among hemoglobinized erythroblasts from adult humans may be achieved in the absence of hereditary mutation or direct genomic manipulation.

Original languageEnglish (US)
Pages (from-to)387-393
Number of pages7
JournalBlood
Volume105
Issue number1
DOIs
StatePublished - Jan 1 2005
Externally publishedYes

Fingerprint

gamma-Globins
Erythroid Precursor Cells
Gene Silencing
Erythropoietin
Genes
Stem Cell Factor
Transforming Growth Factor beta
Erythroblasts
Polymerase chain reaction
Fetal Hemoglobin
Polymerase Chain Reaction
beta-Globins
Globins
Hemoglobins
Cytokines
Gene Expression
Messenger RNA
Mutation
Antibodies
Growth

ASJC Scopus subject areas

  • Immunology
  • Biochemistry
  • Hematology
  • Cell Biology

Cite this

Bhanu, N. V., Trice, T. A., Lee, Y. T., Gantt, N. M., Oneal, P., Schwartz, J. D., ... Miller, J. L. (2005). A sustained and pancellular reversal of gamma-globin gene silencing in adult human erythroid precursor cells. Blood, 105(1), 387-393. https://doi.org/10.1182/blood-2004-04-1599

A sustained and pancellular reversal of gamma-globin gene silencing in adult human erythroid precursor cells. / Bhanu, Natarajan V.; Trice, Tiffany A.; Lee, Y. Terry; Gantt, Nicole M.; Oneal, Patricia; Schwartz, Joseph D.; Noel, Pierre; Miller, Jeffery L.

In: Blood, Vol. 105, No. 1, 01.01.2005, p. 387-393.

Research output: Contribution to journalArticle

Bhanu, NV, Trice, TA, Lee, YT, Gantt, NM, Oneal, P, Schwartz, JD, Noel, P & Miller, JL 2005, 'A sustained and pancellular reversal of gamma-globin gene silencing in adult human erythroid precursor cells', Blood, vol. 105, no. 1, pp. 387-393. https://doi.org/10.1182/blood-2004-04-1599
Bhanu, Natarajan V. ; Trice, Tiffany A. ; Lee, Y. Terry ; Gantt, Nicole M. ; Oneal, Patricia ; Schwartz, Joseph D. ; Noel, Pierre ; Miller, Jeffery L. / A sustained and pancellular reversal of gamma-globin gene silencing in adult human erythroid precursor cells. In: Blood. 2005 ; Vol. 105, No. 1. pp. 387-393.
@article{a902e6a774a6422bb1af4cd7747ce79d,
title = "A sustained and pancellular reversal of gamma-globin gene silencing in adult human erythroid precursor cells",
abstract = "We systematically compared cytokine-mediated increases or decreases in proliferation with globin gene and protein expression in adult human erythroblasts. Despite their opposite effects on growth, stem cell factor (SCF) and transforming growth factor-beta (TGF-B) had synergistic effects with respect to fetal hemoglobin (HbF): average HbF/HbF + adult hemoglobin (HbA) ratio in erythropoietin (EPO) = 1.4 ± 1.0{\%}; EPO + TGF-B = 10.8 ± 1.9{\%}; EPO + SCF = 19.1 ± 6.2{\%}; and EPO + SCF + TGF-B (EST) = 39.3 ± 6.3{\%}. Polymerase chain reaction (PCR) revealed significant increases in gamma-globin transcripts that were balanced by reduced beta-globin transcripts. Single-cell quantitative PCR demonstrated a complete reversal of gamma-globin gene silencing with detectable gamma-globin mRNA in more than 95{\%} of the cells. Immunostaining with HbF antibodies also showed a pancellular distribution in EST (96.2 ± 0.01{\%} HbF positive) compared with a heterocellular distribution in EPO (42.9 ± 0.01{\%} HbF positive). As shown here for the first time, a robust and pancellular reversal of gamma-globin gene silencing among hemoglobinized erythroblasts from adult humans may be achieved in the absence of hereditary mutation or direct genomic manipulation.",
author = "Bhanu, {Natarajan V.} and Trice, {Tiffany A.} and Lee, {Y. Terry} and Gantt, {Nicole M.} and Patricia Oneal and Schwartz, {Joseph D.} and Pierre Noel and Miller, {Jeffery L.}",
year = "2005",
month = "1",
day = "1",
doi = "10.1182/blood-2004-04-1599",
language = "English (US)",
volume = "105",
pages = "387--393",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "1",

}

TY - JOUR

T1 - A sustained and pancellular reversal of gamma-globin gene silencing in adult human erythroid precursor cells

AU - Bhanu, Natarajan V.

AU - Trice, Tiffany A.

AU - Lee, Y. Terry

AU - Gantt, Nicole M.

AU - Oneal, Patricia

AU - Schwartz, Joseph D.

AU - Noel, Pierre

AU - Miller, Jeffery L.

PY - 2005/1/1

Y1 - 2005/1/1

N2 - We systematically compared cytokine-mediated increases or decreases in proliferation with globin gene and protein expression in adult human erythroblasts. Despite their opposite effects on growth, stem cell factor (SCF) and transforming growth factor-beta (TGF-B) had synergistic effects with respect to fetal hemoglobin (HbF): average HbF/HbF + adult hemoglobin (HbA) ratio in erythropoietin (EPO) = 1.4 ± 1.0%; EPO + TGF-B = 10.8 ± 1.9%; EPO + SCF = 19.1 ± 6.2%; and EPO + SCF + TGF-B (EST) = 39.3 ± 6.3%. Polymerase chain reaction (PCR) revealed significant increases in gamma-globin transcripts that were balanced by reduced beta-globin transcripts. Single-cell quantitative PCR demonstrated a complete reversal of gamma-globin gene silencing with detectable gamma-globin mRNA in more than 95% of the cells. Immunostaining with HbF antibodies also showed a pancellular distribution in EST (96.2 ± 0.01% HbF positive) compared with a heterocellular distribution in EPO (42.9 ± 0.01% HbF positive). As shown here for the first time, a robust and pancellular reversal of gamma-globin gene silencing among hemoglobinized erythroblasts from adult humans may be achieved in the absence of hereditary mutation or direct genomic manipulation.

AB - We systematically compared cytokine-mediated increases or decreases in proliferation with globin gene and protein expression in adult human erythroblasts. Despite their opposite effects on growth, stem cell factor (SCF) and transforming growth factor-beta (TGF-B) had synergistic effects with respect to fetal hemoglobin (HbF): average HbF/HbF + adult hemoglobin (HbA) ratio in erythropoietin (EPO) = 1.4 ± 1.0%; EPO + TGF-B = 10.8 ± 1.9%; EPO + SCF = 19.1 ± 6.2%; and EPO + SCF + TGF-B (EST) = 39.3 ± 6.3%. Polymerase chain reaction (PCR) revealed significant increases in gamma-globin transcripts that were balanced by reduced beta-globin transcripts. Single-cell quantitative PCR demonstrated a complete reversal of gamma-globin gene silencing with detectable gamma-globin mRNA in more than 95% of the cells. Immunostaining with HbF antibodies also showed a pancellular distribution in EST (96.2 ± 0.01% HbF positive) compared with a heterocellular distribution in EPO (42.9 ± 0.01% HbF positive). As shown here for the first time, a robust and pancellular reversal of gamma-globin gene silencing among hemoglobinized erythroblasts from adult humans may be achieved in the absence of hereditary mutation or direct genomic manipulation.

UR - http://www.scopus.com/inward/record.url?scp=11144220892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11144220892&partnerID=8YFLogxK

U2 - 10.1182/blood-2004-04-1599

DO - 10.1182/blood-2004-04-1599

M3 - Article

C2 - 15367428

AN - SCOPUS:11144220892

VL - 105

SP - 387

EP - 393

JO - Blood

JF - Blood

SN - 0006-4971

IS - 1

ER -